Clinical Trial Update: Microvascular Function in Primary Aldosteronism

View source ↗

Summary

The trial NCT02096939 evaluating microvascular function in primary aldosteronism and essential hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Essential Hypertension

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Primary Aldosteronism, Essential Hypertension | Status: WITHDRAWN